[
  {
    "question": "What is the main benefit of early detection of breast cancer?",
    "answer": "Emerging Biomarkers for Early Detection of Breast Cancer\n\n\n\nEarly detection of breast cancer significantly improves survival rates"
  },
  {
    "question": "What is the main problem with mammography and ultrasound?",
    "answer": "Current diagnostic techniques include mammography and ultrasound, but they lack specificity"
  },
  {
    "question": "What is the name of the new biomarkers?",
    "answer": "Recent research identifies circulating tumor DNA (ctDNA) and microRNAs as promising non-invasive biomarkers"
  },
  {
    "question": "What is the purpose of this paper?",
    "answer": "This paper discusses the sensitivity and clinical relevance of these molecular tools in the early stages of breast cancer diagnosis."
  },
  {
    "question": "What is the name of the global pandemic?",
    "answer": "The epidemiology and pathogenesis of coronavirus disease (COVID-19) outbreak\n\n\n\nIn late 2019, a novel coronavirus (SARS-CoV-2) was identified in Wuhan, China, and has since led to a global pandemic"
  },
  {
    "question": "What is the purpose of this review?",
    "answer": "This review highlights the epidemiology, clinical features, transmission, and pathogenesis of COVID-19"
  },
  {
    "question": "What is the main mechanism of SARS-CoV-2?",
    "answer": "SARS-CoV-2 enters cells via ACE2 receptors and spreads rapidly, especially in dense populations"
  },
  {
    "question": "What are the symptoms of SARS-CoV-2?",
    "answer": "Symptoms range from mild respiratory illness to severe pneumonia"
  },
  {
    "question": "What is critical for effective treatment and vaccine design?",
    "answer": "Understanding virus-host interactions and immune responses remains critical for effective treatment and vaccine design."
  },
  {
    "question": "What is the name of the metabolic disorder characterized by insulin resistance and chronic hyperglycemia?",
    "answer": "Recent Advances in Type 2 Diabetes Management\n\n\n\nType 2 diabetes mellitus (T2DM) is a metabolic disorder characterized by insulin resistance and chronic hyperglycemia"
  },
  {
    "question": "What are the two most recent therapies for T2DM?",
    "answer": "Recent therapies focus on SGLT2 inhibitors and GLP-1 receptor agonists, which offer improved glycemic control and cardiovascular benefits"
  },
  {
    "question": "What is the purpose of this review?",
    "answer": "This review explores the mechanism, efficacy, and safety of these new drug classes, and highlights the importance of early diagnosis and personalized treatment plans."
  }
]